News

2023 Sep 25

Combination Radiation with Immunotherapy Shows Promise Against “Cold” Breast Cancer Tumors

Researchers at Weill Cornell Medicine have discovered that radiation therapy combined with two types of immunotherapy—one that boosts T cells, and another that boosts dendritic cells—can control tumors in preclinical models... Read more

green and red labeled cells in immunofluorescent image

2023 Sep 13

Study Reveals Why Cancer May Spread To The Spine

The vertebral bones that form the spine are derived from a distinct type of stem cell that secretes a protein favoring tumor metastases, according to a study led by researchers at Weill Cornell Medicine. The discovery opens... Read more

illustration of a transparent body with an orange stomach and a red tumor in it

2023 Aug 23

A New Targeted Treatment Shows Promise for Select Patients with Stomach Cancer

An international phase 3 clinical trial, done in participation with Weill Cornell Medicine and NewYork-Presbyterian, found that a new targeted treatment called zolbetuximab, given in combination with a standard chemotherapy... Read more

Multi-colored circle with an outer ring, and red and blue lines in the center.

2023 Aug 23

New Research Shows How Cancer Rewires a Key Immune Pathway To Spread

A study led by researchers at Memorial Sloan Kettering Cancer Center (MSK) and Weill Cornell Medicine discovered a new relationship between cancer cells and the immune system, and shows how cancer can selfishly hijack a... Read more

blood cells stained with Wright-Giemsa stain

2023 Aug 14

New Technique Illuminates How Abnormal RNA Splicing Leads to Disease

A technique that enables scientists to record gene mutations and patterns of gene activity in individual cells has been extended to cover RNA splicing as well, in a study led by researchers at Weill Cornell Medicine, the New... Read more

Organoid labeled with fluorescent green and red markers

2023 Aug 10

New Gene Editing Tool Helps Zero in on Small Cancer-Linked Mutations

A change in just one letter in the code that makes up a cancer-causing gene can significantly affect how aggressive a tumor is or how well a patient with cancer responds to a particular therapy. A new, very precise gene-... Read more

Drs. Newman and Bea with fellow doctors in Africa.

2023 Aug 03

WCM Doctors Journey to Africa to Treat Breast Cancer Patients

"This work is my heart and soul," says Dr. Lisa Newman. Taking care of breast cancer patients is her passion and one that led her and her colleagues to travel nearly 5,000 miles to Africa several times a year to see patients... Read more

Three white trophies against a red backdrop

2023 Jul 31

Awards and Honors: July 2023

Dr. James Bussel , professor emeritus of pediatrics, was awarded the Henry M. Stratton Medal from the American Society of Hematology (ASH). The award seeks to recognize individuals who have made outstanding contributions to... Read more

Hope Hughes with her wife Kathy Kayse and their 17-year-old son, Justin Kayse-Hughes.

2023 Jul 06

How Immunotherapy Offered a New Lease on Life

“I was one of those people who never gets sick,” she remembers. But one day in the spring of 2017, Hope Hughes noticed a spot of blood in her urine. The busy 64-year-old, who worked as a management consulting executive in... Read more

2023 Jun 29

Tumor Metabolism Atlas Offers a New Way to Discover Cancer Mechanisms

An atlas that catalogues gene activity and the levels of small molecules called metabolites in tumor samples offers a new way of identifying the deep mechanisms of cancer, according to researchers at Weill Cornell Medicine... Read more

2023 Jun 26

National Cancer Institute Grant Targets Cancer Disparities

Weill Cornell Medicine and Columbia University have been awarded a $9.8 million, five-year grant from the National Cancer Institute (NCI), part of the National Institutes of Health, to help combat cancer disparities fueled... Read more

Illustration of DNA folding to bind fluorophore

2023 Jun 21

DNA Can Fold into Complex Shapes to Execute New Functions

DNA can mimic protein functions by folding into elaborate, three-dimensional structures, according to a study from researchers at Weill Cornell Medicine and the National Heart, Lung, and Blood Institute, part of the National... Read more

Tumor cell-derived EVPs induced accumulation of lipid droplets in the mouse liver. Green, lipid droplet. Blue, DAPI. Credit: Gang Wang, Jianlong Li, David Lyden.

2023 May 24

Cancers in Distant Organs Alter Liver Function

Cancers often release molecules into the bloodstream that pathologically alter the liver, shifting it to an inflammatory state, causing fat buildup and impairing its normal detoxifying functions, according to a study from... Read more

2023 May 17

What You Need to Know About Blood Cancers

Myeloproliferative neoplasms (MPNs) are cancers of the blood and bone marrow. They start when something goes awry with hematopoietic stem cells—immature cells that can develop into any type of blood cell. Myeloid cells, also... Read more

2023 May 11

Weill Cornell Medicine Receives Grant from NIH’s Common Fund Program

Weill Cornell Medicine has received a grant from the National Institutes of Health (NIH) as part of a new $140 million Common Fund program to study somatic mosaicism, a phenomenon in which organs and tissues develop... Read more

2023 May 10

Dr. Tobias Meyer Elected to the American Academy of Arts and Sciences

Dr. Tobias Meyer , the Joseph C. Hinsey Professor in Cell and Developmental Biology at Weill Cornell Medicine, has been elected to the American Academy of Arts and Sciences. Founded in 1780, the academy is one of the nation’... Read more

Double exposure of scientist hand holding laboratory test tube. Photo credit: Shutterstock

2023 May 10

Dr. Lisa Roth and Dr. James Lo Elected to the American Society for Clinical Investigation

Dr. James C. Lo , an associate professor of medicine and Dr. Lisa G. Roth , an associate professor of pediatrics, both from Weill Cornell Medicine, were elected members of the American Society for Clinical Investigation (... Read more

2023 May 04

Adding Epigenetic Drug to Standard Chemotherapy Was Effective in Pilot Study for T-cell Lymphoma

Nearly 90 percent of patients with an aggressive subtype of non-Hodgkin lymphoma had their cancer go into remission in a small phase 2 clinical trial testing a treatment aimed at making chemotherapy more effective, according... Read more

2023 Apr 17

Dr. Jedd Wolchok Elected to the American Association for Cancer Research Board of Directors

Dr. Jedd D. Wolchok , the Meyer Director of the Meyer Cancer Center and a professor of medicine, has been elected a member of the American Association for Cancer Research's Board of Directors. The association’s mission is to... Read more

A woman and a man, wife and husband, pose for a formal portrait.

2023 Apr 14

Edward Meyer, Weill Cornell Medicine Board Member and Benefactor, Dies at 96

Edward H. Meyer, member of Weill Cornell Medicine’s Board of Fellows and devoted benefactor, died April 11 in New York, at age 96. A Cornell University alumnus, Meyer ’49, along with his beloved wife Sandra, was a generous... Read more